Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358, United States.
J Med Chem. 2011 Jan 27;54(2):591-602. doi: 10.1021/jm101266s. Epub 2010 Dec 28.
Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors. When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compounds produced hit rates ranging from 29% to 43% for five matrix metalloproteases (MMPs), 24% for anthrax lethal factor (LF), 49% for 5-lipoxygenase (5-LO), and 60% for tyrosinase (TY). The ligand efficiencies (LE) of the fragment hits are excellent, in the range of 0.4-0.8 kcal/mol. The MMP enzymes all generally elicit the same chelators as hits from CFL-1.1; however, the chelator fragments that inhibit structurally unrelated metalloenzymes (LF, 5-LO, TY) vary considerably. To develop more advanced hits, one hit from CFL-1.1, 8-hydroxyquinoline, was elaborated at four different positions around the ring system to generate new fragments. 8-Hydroxyquinoline fragments substituted at either the 5- or 7-positions gave potent hits against MMP-2, with IC(50) values in the low micromolar range. The 8-hydroxyquinoline represents a promising new chelator scaffold for the development of MMP inhibitors that was discovered by use of a metalloprotein-focused chelator fragment library.
基于片段的先导设计(FBLD)已被用于鉴定金属酶抑制剂的新金属结合基团。在 1mM 时筛选,一个螯合剂片段文库(CFL-1.1)的 96 种化合物对五种基质金属蛋白酶(MMPs)的命中率范围为 29%至 43%,炭疽致死因子(LF)为 24%,5-脂氧合酶(5-LO)为 49%,酪氨酸酶(TY)为 60%。片段命中的配体效率(LE)非常出色,范围在 0.4-0.8kcal/mol 之间。MMP 酶通常都能引发与 CFL-1.1 命中相同的螯合剂;然而,抑制结构上不相关的金属酶(LF、5-LO、TY)的螯合剂片段差异很大。为了开发更先进的命中,从 CFL-1.1 中得到的一个命中,8-羟基喹啉,在环系统的四个不同位置进行了修饰,生成了新的片段。8-羟基喹啉片段在 5 或 7 位取代得到了对 MMP-2 有强抑制作用的命中物,IC50 值在低微摩尔范围内。8-羟基喹啉代表了一种有前途的新的螯合剂支架,用于开发 MMP 抑制剂,这是通过使用金属蛋白酶为重点的螯合剂片段文库发现的。